Growth Metrics

LifeStance Health (LFST) Return on Invested Capital (2021 - 2025)

LifeStance Health (LFST) has disclosed Return on Invested Capital for 5 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 2.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 2.0% increase, with the full-year FY2025 number at 0.0%, up 2.0% from a year prior.
  • Return on Invested Capital was 0.0% for Q4 2025 at LifeStance Health, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2025 to a low of 0.29% in Q2 2022.
  • A 5-year average of 0.11% and a median of 0.1% in 2021 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: fell -26bps in 2022, then grew 19bps in 2023.
  • LifeStance Health's Return on Invested Capital stood at 0.24% in 2021, then soared by 47bps to 0.13% in 2022, then grew by 7bps to 0.12% in 2023, then soared by 81bps to 0.02% in 2024, then skyrocketed by 107bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for LFST's Return on Invested Capital are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).